The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Data collaboration software producer Duality Technologies, e-commerce logistics provider Pandion and cybersecurity software developer Adaptive Shield each raised $30m.

The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.

The Benesse and Prosus-backed online learning platform operator has filed to list on Nasdaq, about a year after closing a series F round at a $3.25bn valuation.

MIT spinout Copious Imaging has been acquired by Anduril Industries for an undisclosed amount.

Canon, Kansai Electric Power, Mitsui Fudosan, NEC, NTT Docomo, So-net and T-Gaia were among the investors that scored exits as the CCTV system provider went public.

SoftBank’s SB Opportunity Fund took part in international staffing services provider Ontop's $20m series A round while Emtek bcame digital payment processor Nium's latest corporate shareholder.

The immuno-oncology drug developer’s prospective initial public offering would mark exits for Takeda, Merck Group, Ipsen and Merck & Co.

The fashion rental service has officially filed to go public having raised over $500m from investors including Advance Publications and American Express.

The diversified therapeutics developer has filed to go public in the United States a year after Pfizer contributed to its $310m series A round.